Pharmaceutical

Pharmaceutical Patentability  (Sample Report) Pharmaceutical Patentability (Sample Report)

Pharmaceutical Patentability  (Sample Report)

Features to Search

E1: A soft gelatine capsule consisting of a shell enclosing a filling material. The shell contains a cyclodextrin which is maintained separated from the active ingredient in the filling materia.The shell of the capsule is prepared from a mix containing, by weight:
from 0.7 to 20% of hydroxypropyl-β-cyclodextrin or β-cyclodextrin,
from 20 to 50% by weight of gelatine,
from 1 to 25% by weight of a plasticizer,
from 20 to 50% by weight of water.

E2: The filling material consists of a solution of a poorly water-soluble or water-insoluble active ingredient in an oily solvent/phase.
E3: The active ingredient is selected from the group consisting of progesterone ranging from 10 to 200 mg, liposoluble vitamins as single vitamins or in mixture with other vitamins ranging from 0.001 to 20 mg, and acetylsalicylic acid ranging from 50 to 300 mg.

Search Strategy

Database: Database: AcclaimIP, USPTO, Patentscope, Espacenet, Google Patents.
Keywords:

Set1 Gelatin, Soft Gelatin, Shell, Soft shell
Set2 Capsules, Soft Capsules, Soft Gelatin Capsules
Set3 Drug, Active Ingredient, Lipo soluble Drug.

US Classification Codes with definitions

424/455 Containing emulsions, dispersions, or solutions
424/456 Gelatin